Is BACHEM HOLDING NAMEN AKT (OTCMKTS:BFEHF)’s Fuel Running High? Reports Show Less Sellers

January 13, 2018 - By Peter Erickson

The stock of BACHEM HOLDING NAMEN AKT (OTCMKTS:BFEHF) registered a decrease of 80% in short interest. BFEHF’s total short interest was 400 shares in January as published by FINRA. Its down 80% from 2,000 shares, reported previously. With 100 shares average volume, it will take short sellers 4 days to cover their BFEHF’s short positions.

The stock 11.89% or $0 during the last trading session, reaching $136.5. It is down 0.00% since January 13, 2017 and is . It has underperformed by 16.70% the S&P500.

Bachem Holding AG, a technology-based biochemicals company, provides services to the pharmaceutical and biotechnology industries primarily in Europe and North America. The company has market cap of $2.17 billion. It develops and makes peptide and organic molecules as active pharmaceutical ingredients , as well as biochemicals for research purposes. It has a 45.27 P/E ratio. The firm offers research products, which include catalog products comprising peptides, amino acid derivatives, and biochemicals for peptide research; custom synthesis services; sterile products under the Clinalfa brand; and glycosylated peptides.

More recent Bachem Holding AG (OTCMKTS:BFEHF) news were published by: which released: “Peptide Therapeutics Market: Global Industry Analysis and Opportunity …” on April 14, 2016. Also published the news titled: “Peptide Therapeutics Market 2017-2023: Global Industry Analysis, Trends …” on September 27, 2017.‘s news article titled: “Chiral Chemicals Market Size, Historical Analysis, Global Trends, Opportunity …” with publication date: December 20, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.